Загрузка...

Keytruda in India: Miracle Cancer Drug or Costly Crisis? | Current Affairs | Drishti IAS

GS Studio Foundation Course में एडमिशन के लिए दिए गए लिंक पर क्लिक करें-
हिंदी मीडियम: https://drishti.xyz/GS-Studio-Foundation-Online-Course-Hindi
English Medium: https://drishti.xyz/GS-Studio-Foundation-Online-Course-English
Hinglish Medium: https://drishti.xyz/gs-studio-foundation-online-course-Hinglish

GS Studio Foundation Course की अधिक जानकारी या काउंसलिंग के लिए लिंक पर क्लिक करें –
https://drishti.xyz/GS-Studio-Foundation-Course
 *************************************************************************
Keytruda (pembrolizumab), developed by Merck & Co. and approved by the US Food and Drug Administration in 2014, is one of the world’s leading immunotherapy drugs used to treat cancers such as lung, cervical, breast, and kidney cancer by enabling the body’s immune system to attack cancer cells more effectively. In India, however, its high cost—over ₹1.5 lakh per vial—has made it inaccessible for many patients, even as the country’s cancer burden continues to rise. An investigation by The Indian Express in collaboration with International Consortium of Investigative Journalists has revealed a growing counterfeit market for Keytruda, driven by affordability issues, standardized high dosing, and serious loopholes within hospital systems, including alleged insider involvement. While immunotherapy offers a more targeted approach compared to chemotherapy and radiation and has shown remarkable results even in advanced cancers, challenges related to pricing, access, and regulation remain critical in India’s healthcare system. With the drug’s patent expected to expire in 2028, the arrival of cheaper alternatives may improve accessibility, but until then, ensuring genuine supply and equitable access remains a major concern.
*************************************************************************
महत्त्वपूर्ण प्लेलिस्ट:

1. Drishtikon By Dr. Vikas Divyakirti:
https://drishti.xyz/Drishtikon-by-Dr-Vikas-Divyakirti

2. Videos by Dr. Vikas Divyakriti:
https://drishti.xyz/Videos-DrVikasDivyakirti-Playlist-YT

3. Concept Talk- By Dr. Vikas Divyakirti:
https://drishti.xyz/Concepttalk-DrVikasDivyakirti-Playlist-YT

4. NCERT Foundation Series:
https://drishti.xyz/NCERT-Foundation-Series-Hindi

5. How to Prepare Optional:
https://drishti.xyz/How-to-Prepare-Optional-Hindi

6. Optional Subject Demo Classes:
https://drishti.xyz/Optional-Subject-Demo-Classes

7. Daily Current News:
https://drishti.xyz/Daily-Current-News

8. Simplified Videos:
https://drishti.xyz/Simplified

9. Drishti IAS Special:
https://drishti.xyz/Drishti-IAS-Special

10. Duniya Is Hafte:
https://drishti.xyz/Duniya-Is-Hafte-DIH

11. Topper’s Success Stories:
https://drishti.xyz/Toppers-Success-Stories

12. UPSC Prelims PYQ Analysis:
https://drishti.xyz/UPSC-Prelims-PYQ-Analysis-Hindi

13. UPSC Mock Interview 2024:
https://drishti.xyz/UPSC-2024-Mock-Interview-Hindi-Medium

14. IAS Toppers Talk 2024:
https://drishti.xyz/Toppers-Talk-2024

15. IAS Toppers’ Seminar:
https://drishti.xyz/IAS-Toppers-Seminar

16. IAS Toppers’ Strategy:
https://drishti.xyz/IAS-Toppers-Strategy
*************************************************************************
हमारे प्रमुख कोर्सेज़:

1. GS Foundation Courses:
https://drishti.xyz/GS-foundation-Online-Courses

2. GS Studio Foundation Course (Hindi):
https://drishti.xyz/GS-Studio-Foundation-Online-Course-Hindi

3. GS Studio Foundation Course (Hinglish):
https://drishti.xyz/gs-studio-foundation-online-course-Hinglish

4. GS Studio Foundation Course (English):
https://drishti.xyz/GS-Studio-Foundation-Online-Course-English

5. NCERT Online Courses:
https://drishti.xyz/NCERT-Online-Courses

6. UPSC Optional Subjects Online Courses:
https://drishti.xyz/UPSC-Optional-Subjects-Online-Courses

7. IAS Prelims 2026 Online Courses:
https://drishti.xyz/IAS-Prelims-2026-Online-Courses

8. IAS Mains 2026 Online Courses:
https://drishti.xyz/IAS-Mains-2026-Online-Courses

9. Current Affairs (Prelims + Mains) IAS 2026 Online Courses:
https://drishti.xyz/UPSC-Current-Affairs-P-M-Online-Courses

10. UPSC Prelims 2026 Test Series:
https://drishti.xyz/IAS-Prelims-2026-Test-Series

11. UPSC Mains 2026 Test Series:
https://drishti.xyz/IAS-Mains-2026-Test-Series

12. EPFO Online Course:
https://drishti.xyz/UPSC-EPFO-Online-Courses

13. CAPF Online Courses:
https://drishti.xyz/CAPF-Online-Courses
*************************************************************************
Download Drishti Learning App Now:

iOS:
https://drishti.xyz/DLA-IOS

Android:
https://drishti.xyz/DLA-Android

Windows:
https://drishti.xyz/DLA-Windows
*************************************************************************
Follow Us on Social Media:
https://drishti.xyz/SocialMedia-YT

#Keytruda #CancerTreatment #Immunotherapy #CancerInIndia #HealthcareCrisis #BigPharma #MedicalNews #Oncology #ICIJ #IndianExpress #HealthPolicy #CancerAwareness #PharmaIndustry #BlackMarket #HealthcareIndia

#UPSCPreparation | #CivilServicesExam | #IASPreparation | #UPSC2026 | #UPSC

Видео Keytruda in India: Miracle Cancer Drug or Costly Crisis? | Current Affairs | Drishti IAS канала Drishti IAS
Яндекс.Метрика
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять